Showing results (71-80 of 114) with videos related to
Sort By:
Pageof 12
Alcohol (Fayetteville, N.Y.)|February 16, 2019
Status of inflammation and alcohol use in a 6-month follow-up study of patients with major depressive disorderMari Archer, Onni Niemelä, Kaisa Luoto, et al.Acta Neuropsychiatrica|November 12, 2024
Leptin and leptin receptor gene polymorphisms and depression treatment responseIda-Maria Tavast, Anssi Solismaa, Leo-Pekka Lyytikäinen, et al.Brain and Behavior|August 3, 2021
Electroconvulsive therapy increases temporarily plasma vascular endothelial growth factor in patients with major depressive disorderAnnamari Sorri, Kaija Järventausta, Olli Kampman, et al.Neuroscience Letters|July 12, 2011
Interaction between two HTR2A polymorphisms and gender is associated with treatment response in MDDMerja Viikki, Kaija Huuhka, Esa Leinonen, et al.BMC Psychiatry|April 20, 2013
TPH1 A218C polymorphism and temperament in major depressionKadri Andre, Olli Kampman, Merja Viikki, et al.Neuroscience Letters|February 22, 2011
P2RX7 polymorphisms Gln460Arg and His155Tyr are not associated with major depressive disorder or remission after SSRI or ECTMerja Viikki, Olli Kampman, Sami Anttila, et al.Neuroscience Letters|April 25, 2008
RGS4 polymorphism and response to electroconvulsive therapy in major depressive disorderKaija Huuhka, Olli Kampman, Sami Anttila, et al.Neuroreport|July 11, 2009
5-HTR1A, 5-HTR2A, 5-HTR6, TPH1 and TPH2 polymorphisms and major depressionAri Illi, Eija Setälä-Soikkeli, Merja Viikki, et al.Neuroscience Letters|April 27, 2010
Vascular endothelial growth factor (VEGF) polymorphism is associated with treatment resistant depressionMerja Viikki, Sami Anttila, Olli Kampman, et al.Journal of Affective Disorders|November 29, 2011
Prevalence of metabolic syndrome in subjects with melancholic and non-melancholic depressive symptoms. A Finnish population-based studyJussi Seppälä, Mauno Vanhala, Hannu Kautiainen, et al.Pageof 12